Intensity-modulated Radiotherapy Market Size & Share, by Type (Fixed-Beam, Rotational); End User (Hospitals, Cancer Treatment Centers, Research Institutions); Application (Prostate, Lung, Breast, Brain, & Gynecological Cancer); Radiation Type (Proton, Electron, Photon, Carbon-ion) - Global Supply & Demand Analysis & Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 5652
  • Published Date: Apr 30, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2024-2036

Intensity-modulated Radiotherapy Market size is anticipated to reach USD 57 Billion by the end of 2036, growing at a CAGR of 11% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of intensity-modulated radiotherapy was over USD 32 Billion. The primary driver propelling the growth of the market is the alarming surge in cancer incidence globally.

As the prevalence of cancer continues to rise, there is an escalating demand for advanced and targeted treatment modalities that can effectively combat the disease while minimizing collateral damage to healthy tissues. Cancer, being a multifaceted and complex ailment, necessitates treatment approaches that are not only potent but also precise. IMRT, with its ability to deliver highly focused and customized radiation doses to specific cancerous cells, has emerged as a pivotal solution in modern oncology. According to a report published by the World Health Organization (WHO), the global cancer burden is anticipated to increase to 29.5 million new cancer cases per year by 2040, showcasing a substantial rise from the 19.3 million new cases reported in 2020.

The rising cancer incidence underscores the critical need for advanced treatment modalities such as IMRT to meet the growing demand for precise and effective cancer care. Intensity-modulated radiotherapy is a well-established and widely used technology in the field of radiation oncology.

Additionally, IMRT is a type of advanced radiation therapy that allows for more precise targeting of cancer cells while minimizing damage to surrounding healthy tissues.

Intensity-modulated Radiotherapy Market
Get more information on this report: Request Free Sample PDF

Intensity-modulated Radiotherapy Sector: Growth Drivers and Challenges

Growth Drivers

  • Technological advancements in imaging and treatment planning software - The prominent growth driver for the intensity-modulated radiotherapy market is the continuous evolution and enhancement of imaging and treatment planning software.  Technological advancements play a pivotal role in refining the precision and efficacy of IMRT.
    The integration of advanced imaging modalities, such as positron emission tomography (PET) scanners and magnetic resonance imaging (MRI), into treatment planning allows for more accurate delineation of tumor boundaries. This, in turn, enables oncologists to create highly customized treatment plans, optimizing the therapeutic impact of IMRT. According to recent report, a 20% increase in target volume definition accuracy when using PET-CT-guided IMRT compared to conventional CT-based planning.
  • Favorable reimbursement policies - Various favorable reimbursement policies play a crucial role in driving the adoption of IMRT. As governments and healthcare regulatory bodies recognize the clinical benefits and long-term cost-effectiveness of IMRT over traditional radiation therapies, reimbursement frameworks are adjusted to incentivize healthcare providers to offer this advanced treatment. This financial support encourages clinics and hospitals to invest in the necessary infrastructure and expertise required for delivering IMRT, ultimately boosting its market growth.
  • Increasing focus on patient-centric cancer care - The paradigm shift towards patient-centric healthcare is a significant growth driver for the IMRT market. Patients and healthcare providers alike are increasingly prioritizing treatment modalities that not only effectively combat cancer but also minimize adverse side effects. IMRT's capability to precisely target tumors while sparing surrounding healthy tissues aligns with this patient-centric approach, making it a preferred choice for both clinicians and individuals undergoing cancer treatment.


  • Cost and infrastructure barriers - The further execution of the IMRT requires substantial financial investment in advanced equipment, software, and specialized personnel. Several healthcare facilities, particularly in resource-limited settings, may face challenges in affording and maintaining the infrastructure necessary for IMRT.
    The initial capital costs and ongoing operational expenses can be significant barriers, limiting access to this advanced treatment modality for certain patient populations.
  • The technical complexity and training requirements pose a challenge to market growth
  • Treatment planning and workflow challenges impose additional concerns

Intensity-modulated Radiotherapy Market: Key Insights

Base Year


Forecast Year




Base Year Market Size (2023)

USD 32 Billion

Forecast Year Market Size (2036)

USD 57 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Intensity-modulated Radiotherapy Segmentation

Type (Fixed-Beam, Rotational)

The fixed-beam segment in the intensity-modulated radiotherapy market is estimated to gain the largest revenue share of 60% in the year 2036. One of the key growth drivers for the fixed-beam IMRT segment is its capability to provide enhanced treatment precision and target conformity. Fixed-beam IMRT allows for the precise modulation of radiation intensity from multiple fixed angles, enabling clinicians to conform the radiation dose more closely to the shape of the tumor. This accuracy is crucial in sparing surrounding healthy tissues and critical structures while effectively treating the cancerous cells.

Fixed-beam IMRT excels in treating tumors with complex shapes and irregular geometries. The technique's ability to deliver modulated radiation from multiple fixed directions facilitates the optimization of dose distribution even for challenging tumor configurations. This makes fixed-beam IMRT particularly effective in addressing cancers in anatomically intricate areas where precision is paramount.

End Users (Hospitals, Cancer Treatment Centers, Research Institutions)

The hospitals segment in the intensity-modulated radiotherapy market is expected to garner a significant share in the year 2036. Hospitals, as primary healthcare providers, are at the forefront of offering comprehensive cancer care services. The integration of IMRT within hospital settings is driven by the need to provide patients with a full spectrum of advanced treatment options. IMRT's precision and effectiveness make it a crucial component of hospitals' oncology departments, contributing to their ability to deliver holistic and state-of-the-art cancer care. The hospitals' commitment to training and developing the expertise of healthcare professionals contributes to the growth of the IMRT segment.

Hospitals invest in specialized training programs for radiation oncologists, medical physicists, and radiation therapists to ensure the safe and effective delivery of IMRT. This emphasis on continuous education supports the seamless integration of IMRT into routine clinical practice. As per a survey conducted among hospital-based radiation oncologists revealed a 45% increase in the number of professionals participating in advanced training programs focused on IMRT techniques. Furthermore, this statistic underscores hospitals' dedication to developing and maintaining expertise in the utilization of IMRT.

Our in-depth analysis of the global intensity-modulated radiotherapy market includes the following segments:


  • Fixed-Beam
  • Rotational



          End User

  • Hospitals
  • Cancer Treatment Centers
  • Research Institutions


  • Prostate
  • Lung
  • Breast
  • Brain
  • Gynecological Cancer

          Radiation Type

  • Proton
  • Electron
  • Photon
  • Carbon-ion

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Intensity-modulated Radiotherapy Industry - Regional Synopsis

APAC Market Forecast

The intensity-modulated radiotherapy market in the Asia Pacific region is projected to hold a revenue share of 40% by the end of 2036. A crucial growth driver of IMRT market in the Asia Pacific region is the escalating incidence and prevalence of cancer. Due to the rising population and shifting demographics, there is a heightened burden of cancer cases in the region.

The growing demand for advanced and precise treatment options, such as IMRT, has become imperative in addressing this surge in cancer diagnoses. According to a report by the International Agency for Research on Cancer (IARC), the Asia Pacific region witnessed a 25% increase in new cancer cases over the past decade. This surge highlights the pressing need for advanced treatment modalities like IMRT to effectively manage and treat the growing number of cancer patients in the region.

North American Market Statistics

The intensity-modulated radiotherapy market in the North American region is projected to hold the second-largest share during the forecast period. North America places a strong emphasis on patient-centric care, with patients actively seeking advanced treatment options that offer improved outcomes and quality of life. IMRT, known for its ability to minimize side effects and spare healthy tissues, aligns with the region's commitment to providing personalized and advanced cancer care.

The collaborative efforts between research institutions and healthcare providers in North America contribute significantly to the growth of IMRT. Research initiatives, clinical trials, and collaborative studies enhance the understanding of IMRT's efficacy and broaden its applications in cancer treatment. The growing substantial investment in oncology infrastructure and the establishment of specialized treatment centers dedicated to cancer care are driving the adoption of IMRT in North America.

Research Nester
Intensity-modulated Radiotherapy Market Regional
Get more information on this report: Request Free Sample PDF

Companies Dominating the Intensity-modulated Radiotherapy Landscape


    Key Players

    • Varian Medical Systems
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Elekta AB
    • Accuray Incorporated
    • Siemens Healthineers
    • ViewRay Inc.
    • RaySearch Laboratories AB
    • Mevion Medical Systems
    • Shinva Medical Instrument Co., Ltd.
    • Sumitomo Heavy Industries, Ltd.
    • ProTom International Inc.

In the News

  • Varian Medical Systems - Varian and Nova Scotia Health formed the first multi-disciplinary oncology partnership to facilitate advancements in cancer care. This partnership also creates an opportunity for economic growth. From Nova Scotia office, Varian aims to work on developing a digital imaging concept with feedback from Nova Scotia Health.
  • Elekta AB - Elekta and MIM Software Inc. announced their collaboration to combine the best solutions for advanced treatment in radiation therapy delivery. This collaboration aims to incorporate innovative software solutions that will benefit clinics to by enhancing users’ experience, providing better output in the treatment, and less time spent at hospitals.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 5652
  • Published Date: Apr 30, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Technological advancements in imaging and treatment planning software, favorable reimbursement policies, and increasing focus on patient-centric cancer care are the major factors driving the market growth.

The market size of intensity-modulated radiotherapy is anticipated to attain a CAGR of 11% over the forecast period, i.e., 2024-2036.

The major players in the market are Varian Medical Systems, Elekta AB, Accuray Incorporated, Siemens Healthineers, ViewRay Inc., RaySearch Laboratories AB, Mevion Medical Systems, Shinya Medical Instrument Co., Ltd., Sumitomo Heavy Industries, Ltd., ProTom International Inc., and others.

The fixed-beam segment is anticipated to garner the largest market size of 60% by the end of 2036 and display significant growth opportunities.

The market in the Asia Pacific region is projected to hold the largest market share of 40% by the end of 2036 and provide more business opportunities in the future.
Intensity modulated Radiotherapy Market Report Scope

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying